5.0 months), although the difference did not reach statistical significance ( 91 ).
← all excerpts
TP53-mutated myelodysplastic syndromes and acute myeloid leukemia: a comprehensive overview of targeted approaches.
1
—
—
5.0 months), although the difference did not reach statistical significance ( 91 ).